发明申请
- 专利标题： Antagonists of the bradykinin B1 receptor
- 专利标题（中）： 缓激肽B1受体的拮抗剂
-
申请号： US12082224申请日： 2008-04-08
-
公开(公告)号： US20090137483A1公开(公告)日： 2009-05-28
- 发明人: Gordon Ng , Yue-Sheng Li , Colin V. Gegg , Benny C. Askew, JR. , Thomas Storz , Yuelie Lu , Derin C. D'Amico , Mark A. Jarosinski , Chuan-Fa Liu , Qi Huang
- 申请人： Gordon Ng , Yue-Sheng Li , Colin V. Gegg , Benny C. Askew, JR. , Thomas Storz , Yuelie Lu , Derin C. D'Amico , Mark A. Jarosinski , Chuan-Fa Liu , Qi Huang
- 专利权人： Amgen Inc.
- 当前专利权人： Amgen Inc.
- 主分类号： A61P25/02
- IPC分类号： A61P25/02 ; A61K38/08 ; A61K38/10
摘要：
The present invention relates to composition of matter involving bradykinin B1 receptor antagonist peptides conjugated to a univalent vehicle, including peptides conjugated to univalent PEG. These compositions can be used as therapeutics or prophylactics against diseases or conditions, such as inflammation or pain, linked to the bradykinin B1 receptor.
公开/授权文献
- US08288351B2 Antagonists of the bradykinin B1 receptor 公开/授权日：2012-10-16
信息查询
